Diflorasone Diacetate
Loading...Diflorasone Diacetate Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Diflorasone diacetate cream USP, 0.05% is a high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
History
There is currently no drug history available for this drug.
Other Information
Diflorasone diacetate cream USP, 0.05% contains the active compound diflorasone diacetate, a synthetic corticosteroid for topical dermatological use.
Chemically, diflorasone diacetate is 6α, 9α-difluoro-11β,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21 diacetate, with the empirical formula C26H32F2O7, a molecular weight of 494.5, and the following structural formula:
Each gram of diflorasone diacetate cream USP, 0.05% contains 0.5 mg diflorasone diacetate in a cream base consisting of purified water, citric acid, mineral oil, lanolin alcohol, isopropyl myristate, cetyl alcohol, glyceryl stearate/PEG 100 stearate, polysorbate 60, sorbitan monostearate, polyoxyl 40 stearate, butylated hydroxytoluene, vegetable oil, propylene glycol, monobasic sodium phosphate.
Sources
Diflorasone Diacetate Manufacturers
-
Taro Pharmaceuticals U.s.a., Inc.
![Diflorasone Diacetate Cream [Taro Pharmaceuticals U.s.a., Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Diflorasone Diacetate | Taro Pharmaceuticals U.s.a., Inc.
Diflorasone diacetate cream USP, 0.05% should be applied to the affected area twice daily.
-
E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Diflorasone Diacetate | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Diflorasone Diacetate Cream 0.05% (Emollient) should be applied to the affected areas as a thin film from one to three times daily depending on the severity or resistant nature of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-
E. Fougera & Co., A Division Of Fougera Pharmaceuticals Inc.
Diflorasone Diacetate | E. Fougera & Co., A Division Of Fougera Pharmaceuticals Inc.
Diflorasone Diacetate Cream USP, 0.05% should be applied to the affected area twice daily.
![Diflorasone Diacetate Cream [E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=40be624a-6acd-4001-9869-446695b9fb61&name=dif00-0003-02.jpg)
![Diflorasone Diacetate Cream [E. Fougera & Co., A Division Of Fougera Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=69ad2eb8-1d9b-4a4d-9b88-a5f4db0609d4&name=diflorasone-diacetate-cream-02.jpg)
Login To Your Free Account